Trial completion • Trial completion date • Trial primary completion date • CAR T-Cell Therapy
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • BCL2 (B-cell CLL/lymphoma 2) • BCL6 (B-cell CLL/lymphoma 6)
|
MYC expression • BCL6 rearrangement • BCL2 rearrangement • CD20 negative
|
Keytruda (pembrolizumab) • cyclophosphamide • AUTO3